Portal Veterinary medicinal products

To limit environmental exposure to antibiotics in veterinary medicine treatments
22/06/2022
News

To limit environmental exposure to antibiotics in veterinary medicine treatments

Many antibiotics are used in both humans and animals. As part of the One Health approach, the Veterinary Medicines Monitoring Committee, attached to the Director of Anses-ANMV, has just published an article on the impact of antibiotics on the environment.
Storage of veterinary medicines and recommendations during heatwaves
21/06/2022
News

Storage of veterinary medicines and recommendations during heatwaves

Veterinary medicine quality is vital and must be ensured throughout the pharmaceutical chain, from design until use. Each participant in the chain has an influence on one or more parameters and needs to take precautions to guarantee and maintain veterinary medicine quality. During the summer, especially in cases of high heat, the storage of veterinary medicinal products may be affected; beyond 40 °C, there are risks of irreversible degradation (quality, effectiveness) or even toxicity (formation of degradation products). The French Agency for Veterinary Medicinal Products also makes recommendations for storage of medicinal products and storage conditions during transport. The Agency's recommendations Storage +2°C to +8°C: Store in a refrigerated cabinet with temperature monitoring. Vaccines should be stored in a refrigerated cabinet unless specifically stated otherwise. <25°C to 30°C: In the event of hot weather, avoid prolonged exposure to high temperatures. If there are no specific instructions, store at room temperature. The same precautions should be applied during hot weather. Store medicines in their packaging, away from light and moisture. Store medicines away from other products in order to limit the risk of confusion and/or cross-contamination (if possible in separate refrigerated cabinets): plant protection products, biocides, medicines for human use, nutritional supplements, food, etc. Transport The storage conditions specified in the package leaflet or label should be observed during transport until the veterinary medicine is used. Medicines to be stored between +2°C and +8°C: Transport under conditions that comply with the cold chain but do not cause the product to freeze (refrigerated insulated container without direct contact between the eutectic plates and the medicine's packaging). Medicines to be stored below 25°C or 30°C and medicines to be stored at room temperature: Avoid prolonged exposure to high temperatures. Limit stock kept in cars to what is strictly necessary for immediate use, if possible. Recommandations during heatwaves Generally speaking, temperatures above 40°C expose a drug to the irreversible deterioration of its quality and effectiveness, or even to risks of toxicity due to the formation of degradation products. Medicines to be stored between +2°C and +8°C: These sensitive drugs should be used promptly after removal from the refrigerator, unless the instructions state that the product should come to room temperature before administration. They should be transported under conditions that comply with the cold chain but do not cause the product to freeze (refrigerated insulated container without direct contact between the eutectic plates and the medicine's packaging). The refrigerator temperature should be checked regularly (if possible with a min/max temperature measurement system in case there is a power failure or breakdown). Medicines to be stored below 25°C or 30°C and medicines to be stored at room temperature: During transport, limit exposure to high temperatures such as those frequently encountered in car boots or passenger compartments exposed to direct sunlight. As a precautionary measure, they should be transported in an unrefrigerated insulated container. Where it is not possible to guarantee storage under optimum conditions, exposed products should be replaced regularly. In each case, the product's appearance should be examined when it is opened, as any alteration indicates a change in the properties of the pharmaceutical form and/or a risk of degradation of the active substances. Products that are degraded or exposed to high temperatures must be replaced. The ANMV can offer advice in the event of any doubt and on a case-by-case basis regarding veterinary medicine quality in relation to any adverse storage conditions.
Overview of the European conference on the use of plants in veterinary medicine
20/05/2022
News

Overview of the European conference on the use of plants in veterinary medicine

The conference was organised in several sessions. In the first session, the context of the use of plants in veterinary medicine in the European Union was presented and the various stakeholders (farmers, veterinarians and pharmaceutical industries) were able to share their expectations and problems with the use of veterinary herbal medicines. Secondly, two experts from the Human Committee on Herbal Medicinal Products presented a feedback on the problems encountered in the authorisation of herbal medicinal products for human use compared to conventional chemical medicinal products. Then, the Anses-ANMV gave a feedback on the work carried out by France, in particular on the referral 2014-SA-0083 . Finally, these sessions continued with the presentation of the perspectives at European level by the EMA and the European Commission and the sharing of the views of the participants. Conference overview
Birth control pills for female cats and dogs must be prescribed by a veterinarian
19/05/2022
News

Birth control pills for female cats and dogs must be prescribed by a veterinarian

Birth control pills for pets can have serious side effects. They should therefore only be dispensed on prescription by a veterinarian and used in accordance with a number of recommendations.
Informal meeting of the Committee for Veterinary Medicinal Products (CVMP — CMDv)
30/05/2022

Informal meeting of the Committee for Veterinary Medicinal Products (CVMP — CMDv)

Public : non
As part of the French Presidency of the Council of the European Union (PFUE), the ANMV organises the biannual meeting of the two main bodies involved in the authorisation process for veterinary medicinal products in Europe from 30 May to 2 June 2022: the Coordinating Group on Mutual and Decentralised Recognition Procedures — Veterinary (CMDv) and the Committee for Medicinal Products for Veterinary Use (CVMP), Expert Group at the European Medicines Agency (EMA).
PFUE — European Conference on the Use of Plants in Veterinary Medicine
08/04/2022
News

PFUE — European Conference on the Use of Plants in Veterinary Medicine

As part of the French Presidency of the Council of the European Union (PFUE), the French agency for veterinary medicinal products (Anses-ANMV) organised a European conference on the use of plants in veterinary medicine on 29 March. The conference, intended for the competent European authorities, was held remotely and attended 54 participants from outside the Anses.
Meeting of Heads of Agency (HMA) from 4 to 6 May 2022
12/05/2022
News

Meeting of Heads of Agency (HMA) from 4 to 6 May 2022

The French agency for veterinary medicinal products (Anses-ANMV) organised with Ansm (French agency for human medicines) the second meeting of Heads of Agency (HMA) from 4 to 6 May. The meeting was held at the Palais du Grand Large in Saint Malo with 90 participants from the competent European authorities, the European Commission and the European Medicines Agency (EMA). On the first day, a meeting was organised with stakeholders: representatives of the veterinary medicine industry, veterinarians, farmers and the veterinary diagnosis industry. Among other things, the meeting provided an opportunity to discuss the implementation of the Veterinary Regulations. On May 5th and 6th, the heads of medicines agencies met for a day and a half. At the veterinary session, the European strategy HMA-EMA 2021-2025 on “Big Data” was adopted as well as the Action Plan of the Network of Agencies’ 2025 Strategy. Part of this event was dedicated to medical devices for human use.
A new process for monitoring adverse reactions to veterinary medicines
04/05/2022
News

A new process for monitoring adverse reactions to veterinary medicines

A new EU-wide pharmacovigilance scheme has been launched with the new EU Regulation on veterinary medicinal products. It aims to manage the adverse effects of veterinary medicines and applies to all medicines authorised in at least one European Union country. We put three questions on this new process to Sylviane Laurentie, deputy director of the French Agency for Veterinary Medicinal Products, responsible for inspection, surveillance and pharmacovigilance.
Three new databases for greater transparency on veterinary medicinal products in Europe
07/03/2022
News

Three new databases for greater transparency on veterinary medicinal products in Europe

The new Regulation (EU) No 2019/6 on veterinary medicinal products provides for the creation of three databases, designed to improve access to and sharing of information on these products. Here is an overview of their objectives.

Pages